J&J's $8.2 Billion Talc Settlement Faces Crucial January Assessment
In a pivotal development for Johnson & Johnson, the company’s monumental $8.2 billion settlement over claims related to its talc-based products is set to undergo a significant evaluation in January. This legal maneuver comes on the heels of extensive allegations that J&J’s talcum powder has been linked to cancer, resulting in a slew of lawsuits against the healthcare giant.
Continue reading
J&J Talc Settlement Under Fire: Allegations of Vote Buying Surface
In a dramatic turn of events surrounding Johnson & Johnson’s (J&J) ongoing talc litigation, certain holdouts in a massive bankruptcy settlement have leveled serious accusations against the pharmaceutical giant. They claim that J&J has engaged in unethical practices aimed at swaying votes in favor of its proposed $8.9 billion settlement aimed at resolving thousands of claims related to its talc-based products.
Continue reading